Concepedia
Statistics
Publications
4
Citations
115
H-Index
Active since
1999
Affiliations
National Cancer Institute(Current)
China Medical University
F.‐D. T. Lung is an author at National Cancer Institute specializing in signal transduction, medicine, and drug discovery.
Top concepts
MedicineSignal TransductionCell DeathImmunologyBiochemistryCell BiologyPharmacologyTumor BiologyCell SignalingDrug Discovery
Publications per year
1999–2004
A p21(Waf1/Cip1)carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells.
Masato Mutoh, F.‐D. T. Lung, Yong-jie Long et al. · PubMed · 1999 · 66 citations
Immunology, Cell Death, Cellular Pharmacology +21
Functional preference of the constituent amino acid residues in a phage‐library‐based nonphosphorylated inhibitor of the Grb2‐SH2 domain
F.‐D. T. Lung, Ya‐Qiu Long, Peter P. Roller et al. · Journal of Peptide Research · 2001 · 24 citations
Protein Assembly, Molecular Biology, Chemical Biology +18
Surface plasmon resonance detection of interactions between peptide fragments of N‐telopeptide and its monoclonal antibodies
F.‐D. T. Lung, C.‐H. Chen, C‐J Liou et al. · Journal of Peptide Research · 2004 · 13 citations
Novel peptide inhibitors for Grb2 SH2 domain and their detection by surface plasmon resonance
F.‐D. T. Lung, Jia‐Yin Tsai, Shu-Yie Wei et al. · Journal of Peptide Research · 2002 · 12 citations
1–4 of 4